Platelet aggregation and serum thromboxane B2 level after taking 60 mg/day of aspirin in type 2 diabetic thai patients

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 3, Issue SUPPL. 3, 2011, Pages 47-50

  Wientong, Purida ^a   Jongjarornprasert, Wallaya ^b   Panomvana, Duangchit ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Aspirin; Aspirin resistance; Diabetes; Platelet aggregation; Serum thromboxane level

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; THROMBOXANE B2;

ADULT; AGED; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC PATIENT; DRUG EFFICACY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; THAILAND; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 79957784788     PISSN: 09751491     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Calvin AD, Aggarwal NR, Murad MH, Shi Q, Elamin MB, Geske JB et al. Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes. Diabetes Care 2009; 32: 2300-2306.
2. Pulcinelli FM, Biasucci LM, Riondino S, Giubilato S, Leo A, DiRenzo L. COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment. Eur Heart J 2009; 30: 1279-1286.
3. Tohgi H, Konno S, Tamura K, Kimura B, Kawano K. Effects of Low-to-High Doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and protacyclin. Stroke 1992; 23: 1400-1403.
4. Patrono C. Aspirin resistance: definition, mechanisms and clinical read-outs. J Thromb Haemost 2003; 1: 1710-1713.
5. Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet 2006; 367: 606-617.
6. Cambria-Kiely JA, Gandhi PJ. Possible mechanisms of aspirin resistance. J Thromb Thrombolysis 2002; 13: 49-56.
7. Gum PA, Kottke-Marchant K, Poggio ED, Gurm H, Welsh PA, Brooks L et al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 2001; 88: 230-235.
8. Fateh-Moghadam S, Plockinger U, Cabeza N, Htun P, Reuter T, Ersel S et al. Prevalence of aspirin resistance in patients with type 2 diabetes. Acta Diabetol 2005; 42: 99-103.
9. Wong S, Appleberg M, Ward CM, Lewis DR. Aspirin Resistance in Cardiovascular Disease: A Review. Eur J Vasc Endovasc Surg 2004; 27: 456-465.
10. Hovens MMC, Snoep JD, Eikenboom JCJ, van der Bom JG, Mertens BJA, Huisman MV. Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review. Am Heart J 2007; 153: 175-181.
11. Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes care 2007; 30: 162-172.
12. Campbell CL, Smyth S, Montalescot G, Steinhubl SR. Aspirin dose for the prevention of cardiovascular disease: a systematic review. JAMA 2007; 297: 2018-2024.
13. Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D et al. Aspirin for primary prevention of cardiovascular events in people with diabetes. J Am Coll Cardiol 2010; 55: 2878-2886.
14. DiChiara J, Bliden KP, Tantry US, Hamed MS, Antonino MJ, Suarez TA et al. The Effect of aspirin dosing on platelet function in diabetic and nondiabetic patients. An analysis from the aspirin-induced platelet effect (ASPECT) study. Diabetes 2007; 56: 3014-3019.
15. Watala C, Pluta J, Golanski J, Rozalski M, Czyz M, Trojanowski Zet al. Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin. J Mol Med 2005; 83: 148-158.
16. Yassine HN, Davis-Gorman G, Stump CS, Thomson SS, Peterson J, McDonagh PF. Clinical determinants of aspirin resistance in diabetes. Diabetes Res Clin Pract 2010; 90: e19-e21.
17. Albert SG, Hasnain BI, Ritter DG, Joist JH, Mooradian AD. Aspirin sensitivity of platelet aggregation in diabetes mellitus. Diabetes Res Clin Pract 2005; 70: 195-199.